Business Development
Donor Landscape Analysis​
​
​Global Development Support conducted a funding landscape analysis for Africa, on behalf of a leader in the pharmaceutical industry. This included an analysis of the current aid environment and donor landscape including the priorities, programmatic focus, geographical presence and funding priorities and distribution of donors (both traditional and non-traditional) and partners working across the region; identification of new aid/resource modalities and partnerships; and an analysis of global health initiatives on the continent dealing with the quality of medicines.
A four-member GDS team conducted an analysis of sixteen multinational donors, nine bilateral donors, six global health initiatives, 25 foundations, 29 pharmaceutical companies, four multinational companies, and three inter-governmental regional organizations. The primary source of information was the internet, industry contacts in different countries, and in some cases the team was able to draw on personal experience with a donor to fill out the narrative. Telephone calls were made to large donors.
It was found that past patterns of donor support were an imperfect guide to forecasting future priorities and funding levels. This was particularly true for the smaller donors or those that try to be responsive. Most donors have spent their health dollars on maternal, neonatal and child health and infectious diseases. Few donors have made a significant commitment to health system strengthening, and even fewer to ensuring the quality of drugs and the supply chain. While every donor cautions against the perils of substandard medicines, few follow up with tangible support.
Market Analysis
​
GDS conducted market analyses for two US firms to identify business opportunities in Asia. The work involved analyses of donor priorities and funding levels as well as country governments’ development strategies. Information was collected from secondary sources and from meetings with donors and governments. The analyses included assessments of the competition, their strengths and weaknesses and current portfolios. GDS also estimated the costs of operating offices and running business in select countries.